Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
40.93
+0.12 (0.29%)
At close: Apr 16, 2026, 4:00 PM EDT
40.88
-0.05 (-0.12%)
After-hours: Apr 16, 2026, 6:27 PM EDT
Novo Nordisk (NVO) Revenue by Segment
History
| Date | Diabetes | Obesity | Rare Disease |
|---|---|---|---|
| Sep 30, 2025 | 33.74B | 12.80B | 3.14B |
| Jun 30, 2025 | 33.54B | 12.43B | 3.12B |
| Mar 31, 2025 | 33.33B | 11.42B | 2.97B |
| Dec 31, 2024 | 32.52B | 10.25B | 2.93B |
| Sep 30, 2024 | 31.18B | 8.65B | 2.76B |
| Jun 30, 2024 | 30.34B | 7.62B | 2.65B |
| Mar 31, 2024 | 28.72B | 7.06B | 2.67B |
| Dec 31, 2023 | 27.30B | 6.55B | 2.70B |
| Sep 30, 2023 | 25.37B | 5.65B | 2.75B |
| Jun 30, 2023 | 24.35B | 4.40B | 2.94B |
| Mar 31, 2023 | 23.17B | 3.35B | 3.11B |
| Dec 31, 2022 | 21.96B | 2.65B | 3.23B |
| Sep 30, 2022 | 20.93B | 2.18B | 3.21B |
| Jun 30, 2022 | 19.76B | 1.87B | 3.12B |
| Mar 31, 2022 | 18.76B | 1.61B | 3.08B |
| Dec 31, 2021 | 17.82B | 1.32B | 3.02B |
| Sep 30, 2021 | 16.63B | 1.13B | 2.98B |
| Jun 30, 2021 | 15.85B | 978.38M | 3.03B |
| Mar 31, 2021 | 15.53B | 891.81M | 3.00B |
| Dec 31, 2020 | 15.29B | 893.86M | 3.02B |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.